nodes	percent_of_prediction	percent_of_DWPC	metapath
Alosetron—CYP2E1—Dacarbazine—sarcoma	0.182	0.232	CbGbCtD
Alosetron—CYP2E1—Mitoxantrone—sarcoma	0.141	0.18	CbGbCtD
Alosetron—CYP1A2—Dacarbazine—sarcoma	0.105	0.134	CbGbCtD
Alosetron—CYP3A4—Thiotepa—sarcoma	0.0996	0.127	CbGbCtD
Alosetron—CYP2E1—Etoposide—sarcoma	0.0891	0.113	CbGbCtD
Alosetron—CYP1A2—Etoposide—sarcoma	0.0515	0.0655	CbGbCtD
Alosetron—CYP3A4—Mitoxantrone—sarcoma	0.0428	0.0544	CbGbCtD
Alosetron—CYP3A4—Vincristine—sarcoma	0.0295	0.0375	CbGbCtD
Alosetron—CYP3A4—Etoposide—sarcoma	0.027	0.0343	CbGbCtD
Alosetron—CYP3A4—Doxorubicin—sarcoma	0.0184	0.0234	CbGbCtD
Alosetron—Ulcer—Etoposide—sarcoma	0.00137	0.00643	CcSEcCtD
Alosetron—Polyuria—Vincristine—sarcoma	0.00133	0.00621	CcSEcCtD
Alosetron—Folliculitis—Epirubicin—sarcoma	0.00116	0.00543	CcSEcCtD
Alosetron—Alanine aminotransferase increased—Thiotepa—sarcoma	0.00116	0.00542	CcSEcCtD
Alosetron—Nail disorder—Epirubicin—sarcoma	0.00112	0.00526	CcSEcCtD
Alosetron—Folliculitis—Doxorubicin—sarcoma	0.00107	0.00502	CcSEcCtD
Alosetron—Burning sensation—Epirubicin—sarcoma	0.00105	0.00491	CcSEcCtD
Alosetron—Nail disorder—Doxorubicin—sarcoma	0.00104	0.00487	CcSEcCtD
Alosetron—Abdominal pain upper—Mitoxantrone—sarcoma	0.00104	0.00485	CcSEcCtD
Alosetron—Ileus—Epirubicin—sarcoma	0.00103	0.00482	CcSEcCtD
Alosetron—Hyperglycaemia—Thiotepa—sarcoma	0.00102	0.0048	CcSEcCtD
Alosetron—Laryngitis—Epirubicin—sarcoma	0.00101	0.00473	CcSEcCtD
Alosetron—Alanine aminotransferase increased—Mitoxantrone—sarcoma	0.001	0.00468	CcSEcCtD
Alosetron—Jaundice—Thiotepa—sarcoma	0.000986	0.00462	CcSEcCtD
Alosetron—Dermatitis atopic—Epirubicin—sarcoma	0.000984	0.00461	CcSEcCtD
Alosetron—Burning sensation—Doxorubicin—sarcoma	0.00097	0.00454	CcSEcCtD
Alosetron—Ileus—Doxorubicin—sarcoma	0.000952	0.00446	CcSEcCtD
Alosetron—Fungal infection—Epirubicin—sarcoma	0.000943	0.00442	CcSEcCtD
Alosetron—Laryngitis—Doxorubicin—sarcoma	0.000935	0.00438	CcSEcCtD
Alosetron—Haemoglobin—Thiotepa—sarcoma	0.000913	0.00428	CcSEcCtD
Alosetron—Upper respiratory tract infection—Mitoxantrone—sarcoma	0.000911	0.00427	CcSEcCtD
Alosetron—Dermatitis atopic—Doxorubicin—sarcoma	0.00091	0.00427	CcSEcCtD
Alosetron—Haemorrhage—Thiotepa—sarcoma	0.000908	0.00426	CcSEcCtD
Alosetron—Hepatitis—Dactinomycin—sarcoma	0.000901	0.00422	CcSEcCtD
Alosetron—Depression—Vincristine—sarcoma	0.000894	0.00419	CcSEcCtD
Alosetron—Hyperglycaemia—Mitoxantrone—sarcoma	0.000884	0.00414	CcSEcCtD
Alosetron—Fungal infection—Doxorubicin—sarcoma	0.000873	0.00409	CcSEcCtD
Alosetron—Sweating—Vincristine—sarcoma	0.00086	0.00403	CcSEcCtD
Alosetron—Jaundice—Mitoxantrone—sarcoma	0.000852	0.00399	CcSEcCtD
Alosetron—Urinary tract infection—Mitoxantrone—sarcoma	0.000849	0.00398	CcSEcCtD
Alosetron—Cramp muscle—Etoposide—sarcoma	0.000849	0.00398	CcSEcCtD
Alosetron—Sweating—Mitoxantrone—sarcoma	0.000838	0.00392	CcSEcCtD
Alosetron—Alanine aminotransferase increased—Etoposide—sarcoma	0.000832	0.0039	CcSEcCtD
Alosetron—Sinusitis—Mitoxantrone—sarcoma	0.00082	0.00384	CcSEcCtD
Alosetron—Arrhythmia—Thiotepa—sarcoma	0.000811	0.0038	CcSEcCtD
Alosetron—Alopecia—Thiotepa—sarcoma	0.000802	0.00376	CcSEcCtD
Alosetron—Hypoaesthesia—Vincristine—sarcoma	0.000801	0.00375	CcSEcCtD
Alosetron—Alopecia—Dactinomycin—sarcoma	0.000796	0.00373	CcSEcCtD
Alosetron—Haemoglobin—Mitoxantrone—sarcoma	0.000788	0.00369	CcSEcCtD
Alosetron—Haemorrhage—Mitoxantrone—sarcoma	0.000784	0.00367	CcSEcCtD
Alosetron—Hepatitis—Mitoxantrone—sarcoma	0.000784	0.00367	CcSEcCtD
Alosetron—Ulcer—Epirubicin—sarcoma	0.00077	0.00361	CcSEcCtD
Alosetron—Bone pain—Epirubicin—sarcoma	0.00076	0.00356	CcSEcCtD
Alosetron—Ill-defined disorder—Dactinomycin—sarcoma	0.000728	0.00341	CcSEcCtD
Alosetron—Abnormal dreams—Epirubicin—sarcoma	0.00072	0.00337	CcSEcCtD
Alosetron—Ulcer—Doxorubicin—sarcoma	0.000712	0.00334	CcSEcCtD
Alosetron—Alopecia—Vincristine—sarcoma	0.000712	0.00333	CcSEcCtD
Alosetron—Cystitis noninfective—Epirubicin—sarcoma	0.000711	0.00333	CcSEcCtD
Alosetron—Jaundice—Etoposide—sarcoma	0.000708	0.00332	CcSEcCtD
Alosetron—Malaise—Dactinomycin—sarcoma	0.000708	0.00332	CcSEcCtD
Alosetron—Bone pain—Doxorubicin—sarcoma	0.000703	0.0033	CcSEcCtD
Alosetron—Cystitis—Epirubicin—sarcoma	0.000703	0.00329	CcSEcCtD
Alosetron—Arrhythmia—Mitoxantrone—sarcoma	0.000701	0.00328	CcSEcCtD
Alosetron—Colitis—Epirubicin—sarcoma	0.000699	0.00328	CcSEcCtD
Alosetron—Alopecia—Mitoxantrone—sarcoma	0.000693	0.00325	CcSEcCtD
Alosetron—Cough—Thiotepa—sarcoma	0.00069	0.00323	CcSEcCtD
Alosetron—Hypertension—Thiotepa—sarcoma	0.000683	0.0032	CcSEcCtD
Alosetron—Myalgia—Thiotepa—sarcoma	0.000673	0.00315	CcSEcCtD
Alosetron—Anxiety—Thiotepa—sarcoma	0.000671	0.00314	CcSEcCtD
Alosetron—Myalgia—Dactinomycin—sarcoma	0.000668	0.00313	CcSEcCtD
Alosetron—Abnormal dreams—Doxorubicin—sarcoma	0.000666	0.00312	CcSEcCtD
Alosetron—Discomfort—Dactinomycin—sarcoma	0.00066	0.00309	CcSEcCtD
Alosetron—Bladder pain—Epirubicin—sarcoma	0.000658	0.00308	CcSEcCtD
Alosetron—Cystitis noninfective—Doxorubicin—sarcoma	0.000658	0.00308	CcSEcCtD
Alosetron—Cystitis—Doxorubicin—sarcoma	0.000651	0.00305	CcSEcCtD
Alosetron—Confusional state—Thiotepa—sarcoma	0.000651	0.00305	CcSEcCtD
Alosetron—Hypoaesthesia—Etoposide—sarcoma	0.000649	0.00304	CcSEcCtD
Alosetron—Colitis—Doxorubicin—sarcoma	0.000647	0.00303	CcSEcCtD
Alosetron—Infection—Thiotepa—sarcoma	0.000641	0.003	CcSEcCtD
Alosetron—Infection—Dactinomycin—sarcoma	0.000636	0.00298	CcSEcCtD
Alosetron—Ill-defined disorder—Mitoxantrone—sarcoma	0.000633	0.00297	CcSEcCtD
Alosetron—Skin disorder—Thiotepa—sarcoma	0.000627	0.00294	CcSEcCtD
Alosetron—Malaise—Mitoxantrone—sarcoma	0.000616	0.00288	CcSEcCtD
Alosetron—Bladder pain—Doxorubicin—sarcoma	0.000609	0.00285	CcSEcCtD
Alosetron—Hypertension—Vincristine—sarcoma	0.000605	0.00284	CcSEcCtD
Alosetron—Myalgia—Vincristine—sarcoma	0.000597	0.0028	CcSEcCtD
Alosetron—Cough—Mitoxantrone—sarcoma	0.000596	0.00279	CcSEcCtD
Alosetron—Hypertension—Mitoxantrone—sarcoma	0.000589	0.00276	CcSEcCtD
Alosetron—Eczema—Epirubicin—sarcoma	0.000588	0.00276	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Thiotepa—sarcoma	0.000588	0.00275	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Dactinomycin—sarcoma	0.000583	0.00273	CcSEcCtD
Alosetron—Myalgia—Mitoxantrone—sarcoma	0.000581	0.00272	CcSEcCtD
Alosetron—Anxiety—Mitoxantrone—sarcoma	0.000579	0.00271	CcSEcCtD
Alosetron—Alopecia—Etoposide—sarcoma	0.000576	0.0027	CcSEcCtD
Alosetron—Discomfort—Mitoxantrone—sarcoma	0.000574	0.00269	CcSEcCtD
Alosetron—Infection—Vincristine—sarcoma	0.000568	0.00266	CcSEcCtD
Alosetron—Confusional state—Mitoxantrone—sarcoma	0.000562	0.00263	CcSEcCtD
Alosetron—Fatigue—Thiotepa—sarcoma	0.000556	0.00261	CcSEcCtD
Alosetron—Infection—Mitoxantrone—sarcoma	0.000554	0.00259	CcSEcCtD
Alosetron—Hyperhidrosis—Vincristine—sarcoma	0.000553	0.00259	CcSEcCtD
Alosetron—Fatigue—Dactinomycin—sarcoma	0.000552	0.00259	CcSEcCtD
Alosetron—Constipation—Thiotepa—sarcoma	0.000552	0.00259	CcSEcCtD
Alosetron—Pain—Thiotepa—sarcoma	0.000552	0.00259	CcSEcCtD
Alosetron—Pain—Dactinomycin—sarcoma	0.000548	0.00257	CcSEcCtD
Alosetron—Muscle spasms—Etoposide—sarcoma	0.000546	0.00256	CcSEcCtD
Alosetron—Eczema—Doxorubicin—sarcoma	0.000544	0.00255	CcSEcCtD
Alosetron—Hypoglycaemia—Epirubicin—sarcoma	0.000542	0.00254	CcSEcCtD
Alosetron—Skin disorder—Mitoxantrone—sarcoma	0.000541	0.00254	CcSEcCtD
Alosetron—Hyperhidrosis—Mitoxantrone—sarcoma	0.000539	0.00252	CcSEcCtD
Alosetron—Feeling abnormal—Thiotepa—sarcoma	0.000532	0.00249	CcSEcCtD
Alosetron—Feeling abnormal—Dactinomycin—sarcoma	0.000528	0.00247	CcSEcCtD
Alosetron—Ill-defined disorder—Etoposide—sarcoma	0.000527	0.00247	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Vincristine—sarcoma	0.000521	0.00244	CcSEcCtD
Alosetron—Urticaria—Thiotepa—sarcoma	0.000513	0.0024	CcSEcCtD
Alosetron—Malaise—Etoposide—sarcoma	0.000512	0.0024	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.000508	0.00238	CcSEcCtD
Alosetron—Hypoglycaemia—Doxorubicin—sarcoma	0.000501	0.00235	CcSEcCtD
Alosetron—Cough—Etoposide—sarcoma	0.000496	0.00232	CcSEcCtD
Alosetron—Fatigue—Vincristine—sarcoma	0.000493	0.00231	CcSEcCtD
Alosetron—Hypertension—Etoposide—sarcoma	0.00049	0.0023	CcSEcCtD
Alosetron—Constipation—Vincristine—sarcoma	0.000489	0.00229	CcSEcCtD
Alosetron—Pain—Vincristine—sarcoma	0.000489	0.00229	CcSEcCtD
Alosetron—Abdominal pain upper—Epirubicin—sarcoma	0.000483	0.00226	CcSEcCtD
Alosetron—Fatigue—Mitoxantrone—sarcoma	0.00048	0.00225	CcSEcCtD
Alosetron—Discomfort—Etoposide—sarcoma	0.000478	0.00224	CcSEcCtD
Alosetron—Constipation—Mitoxantrone—sarcoma	0.000476	0.00223	CcSEcCtD
Alosetron—Pain—Mitoxantrone—sarcoma	0.000476	0.00223	CcSEcCtD
Alosetron—Hypersensitivity—Thiotepa—sarcoma	0.000475	0.00223	CcSEcCtD
Alosetron—Nasopharyngitis—Epirubicin—sarcoma	0.000473	0.00221	CcSEcCtD
Alosetron—Hypersensitivity—Dactinomycin—sarcoma	0.000472	0.00221	CcSEcCtD
Alosetron—Gastritis—Epirubicin—sarcoma	0.000468	0.00219	CcSEcCtD
Alosetron—Confusional state—Etoposide—sarcoma	0.000467	0.00219	CcSEcCtD
Alosetron—Alanine aminotransferase increased—Epirubicin—sarcoma	0.000466	0.00218	CcSEcCtD
Alosetron—Asthenia—Thiotepa—sarcoma	0.000463	0.00217	CcSEcCtD
Alosetron—Infection—Etoposide—sarcoma	0.00046	0.00216	CcSEcCtD
Alosetron—Abdominal distension—Epirubicin—sarcoma	0.00046	0.00215	CcSEcCtD
Alosetron—Asthenia—Dactinomycin—sarcoma	0.000459	0.00215	CcSEcCtD
Alosetron—Feeling abnormal—Mitoxantrone—sarcoma	0.000459	0.00215	CcSEcCtD
Alosetron—Skin disorder—Etoposide—sarcoma	0.00045	0.00211	CcSEcCtD
Alosetron—Hyperhidrosis—Etoposide—sarcoma	0.000448	0.0021	CcSEcCtD
Alosetron—Abdominal pain upper—Doxorubicin—sarcoma	0.000447	0.00209	CcSEcCtD
Alosetron—Urticaria—Mitoxantrone—sarcoma	0.000443	0.00207	CcSEcCtD
Alosetron—Nasopharyngitis—Doxorubicin—sarcoma	0.000437	0.00205	CcSEcCtD
Alosetron—Gastritis—Doxorubicin—sarcoma	0.000433	0.00203	CcSEcCtD
Alosetron—Alanine aminotransferase increased—Doxorubicin—sarcoma	0.000431	0.00202	CcSEcCtD
Alosetron—Abdominal distension—Doxorubicin—sarcoma	0.000426	0.00199	CcSEcCtD
Alosetron—Upper respiratory tract infection—Epirubicin—sarcoma	0.000425	0.00199	CcSEcCtD
Alosetron—Pollakiuria—Epirubicin—sarcoma	0.000422	0.00198	CcSEcCtD
Alosetron—Hypersensitivity—Vincristine—sarcoma	0.000422	0.00197	CcSEcCtD
Alosetron—Hyperglycaemia—Epirubicin—sarcoma	0.000412	0.00193	CcSEcCtD
Alosetron—Hypersensitivity—Mitoxantrone—sarcoma	0.00041	0.00192	CcSEcCtD
Alosetron—Asthenia—Vincristine—sarcoma	0.00041	0.00192	CcSEcCtD
Alosetron—Vomiting—Thiotepa—sarcoma	0.00041	0.00192	CcSEcCtD
Alosetron—Vomiting—Dactinomycin—sarcoma	0.000407	0.00191	CcSEcCtD
Alosetron—Rash—Thiotepa—sarcoma	0.000407	0.00191	CcSEcCtD
Alosetron—Dermatitis—Thiotepa—sarcoma	0.000406	0.0019	CcSEcCtD
Alosetron—Headache—Thiotepa—sarcoma	0.000404	0.00189	CcSEcCtD
Alosetron—Rash—Dactinomycin—sarcoma	0.000404	0.00189	CcSEcCtD
Alosetron—Asthenia—Mitoxantrone—sarcoma	0.0004	0.00187	CcSEcCtD
Alosetron—Fatigue—Etoposide—sarcoma	0.0004	0.00187	CcSEcCtD
Alosetron—Jaundice—Epirubicin—sarcoma	0.000397	0.00186	CcSEcCtD
Alosetron—Constipation—Etoposide—sarcoma	0.000396	0.00186	CcSEcCtD
Alosetron—Pain—Etoposide—sarcoma	0.000396	0.00186	CcSEcCtD
Alosetron—Urinary tract infection—Epirubicin—sarcoma	0.000396	0.00186	CcSEcCtD
Alosetron—Upper respiratory tract infection—Doxorubicin—sarcoma	0.000393	0.00184	CcSEcCtD
Alosetron—Sweating—Epirubicin—sarcoma	0.00039	0.00183	CcSEcCtD
Alosetron—Pollakiuria—Doxorubicin—sarcoma	0.00039	0.00183	CcSEcCtD
Alosetron—Nausea—Thiotepa—sarcoma	0.000383	0.0018	CcSEcCtD
Alosetron—Sinusitis—Epirubicin—sarcoma	0.000382	0.00179	CcSEcCtD
Alosetron—Feeling abnormal—Etoposide—sarcoma	0.000382	0.00179	CcSEcCtD
Alosetron—Hyperglycaemia—Doxorubicin—sarcoma	0.000381	0.00179	CcSEcCtD
Alosetron—Nausea—Dactinomycin—sarcoma	0.00038	0.00178	CcSEcCtD
Alosetron—Urticaria—Etoposide—sarcoma	0.000368	0.00173	CcSEcCtD
Alosetron—Haemoglobin—Epirubicin—sarcoma	0.000368	0.00172	CcSEcCtD
Alosetron—Jaundice—Doxorubicin—sarcoma	0.000367	0.00172	CcSEcCtD
Alosetron—Urinary tract infection—Doxorubicin—sarcoma	0.000366	0.00172	CcSEcCtD
Alosetron—Hepatitis—Epirubicin—sarcoma	0.000366	0.00171	CcSEcCtD
Alosetron—Haemorrhage—Epirubicin—sarcoma	0.000366	0.00171	CcSEcCtD
Alosetron—Hypoaesthesia—Epirubicin—sarcoma	0.000364	0.0017	CcSEcCtD
Alosetron—Vomiting—Vincristine—sarcoma	0.000364	0.0017	CcSEcCtD
Alosetron—Sweating—Doxorubicin—sarcoma	0.000361	0.00169	CcSEcCtD
Alosetron—Rash—Vincristine—sarcoma	0.000361	0.00169	CcSEcCtD
Alosetron—Dermatitis—Vincristine—sarcoma	0.00036	0.00169	CcSEcCtD
Alosetron—Headache—Vincristine—sarcoma	0.000358	0.00168	CcSEcCtD
Alosetron—Vomiting—Mitoxantrone—sarcoma	0.000354	0.00166	CcSEcCtD
Alosetron—Sinusitis—Doxorubicin—sarcoma	0.000354	0.00166	CcSEcCtD
Alosetron—Rash—Mitoxantrone—sarcoma	0.000351	0.00165	CcSEcCtD
Alosetron—Dermatitis—Mitoxantrone—sarcoma	0.000351	0.00164	CcSEcCtD
Alosetron—Headache—Mitoxantrone—sarcoma	0.000349	0.00164	CcSEcCtD
Alosetron—Hypersensitivity—Etoposide—sarcoma	0.000341	0.0016	CcSEcCtD
Alosetron—Haemoglobin—Doxorubicin—sarcoma	0.00034	0.00159	CcSEcCtD
Alosetron—Nausea—Vincristine—sarcoma	0.00034	0.00159	CcSEcCtD
Alosetron—Hepatitis—Doxorubicin—sarcoma	0.000338	0.00159	CcSEcCtD
Alosetron—Haemorrhage—Doxorubicin—sarcoma	0.000338	0.00159	CcSEcCtD
Alosetron—Hypoaesthesia—Doxorubicin—sarcoma	0.000337	0.00158	CcSEcCtD
Alosetron—Asthenia—Etoposide—sarcoma	0.000333	0.00156	CcSEcCtD
Alosetron—Nausea—Mitoxantrone—sarcoma	0.000331	0.00155	CcSEcCtD
Alosetron—Arrhythmia—Epirubicin—sarcoma	0.000327	0.00153	CcSEcCtD
Alosetron—Alopecia—Epirubicin—sarcoma	0.000323	0.00151	CcSEcCtD
Alosetron—Flatulence—Epirubicin—sarcoma	0.000314	0.00147	CcSEcCtD
Alosetron—Muscle spasms—Epirubicin—sarcoma	0.000306	0.00143	CcSEcCtD
Alosetron—Arrhythmia—Doxorubicin—sarcoma	0.000302	0.00142	CcSEcCtD
Alosetron—Alopecia—Doxorubicin—sarcoma	0.000299	0.0014	CcSEcCtD
Alosetron—Ill-defined disorder—Epirubicin—sarcoma	0.000295	0.00138	CcSEcCtD
Alosetron—Vomiting—Etoposide—sarcoma	0.000295	0.00138	CcSEcCtD
Alosetron—Rash—Etoposide—sarcoma	0.000292	0.00137	CcSEcCtD
Alosetron—Dermatitis—Etoposide—sarcoma	0.000292	0.00137	CcSEcCtD
Alosetron—Headache—Etoposide—sarcoma	0.00029	0.00136	CcSEcCtD
Alosetron—Flatulence—Doxorubicin—sarcoma	0.00029	0.00136	CcSEcCtD
Alosetron—Malaise—Epirubicin—sarcoma	0.000287	0.00134	CcSEcCtD
Alosetron—Muscle spasms—Doxorubicin—sarcoma	0.000283	0.00133	CcSEcCtD
Alosetron—Cough—Epirubicin—sarcoma	0.000278	0.0013	CcSEcCtD
Alosetron—Nausea—Etoposide—sarcoma	0.000275	0.00129	CcSEcCtD
Alosetron—Hypertension—Epirubicin—sarcoma	0.000275	0.00129	CcSEcCtD
Alosetron—Ill-defined disorder—Doxorubicin—sarcoma	0.000273	0.00128	CcSEcCtD
Alosetron—Myalgia—Epirubicin—sarcoma	0.000271	0.00127	CcSEcCtD
Alosetron—Anxiety—Epirubicin—sarcoma	0.00027	0.00127	CcSEcCtD
Alosetron—Discomfort—Epirubicin—sarcoma	0.000268	0.00125	CcSEcCtD
Alosetron—Malaise—Doxorubicin—sarcoma	0.000266	0.00124	CcSEcCtD
Alosetron—Dry mouth—Epirubicin—sarcoma	0.000265	0.00124	CcSEcCtD
Alosetron—Confusional state—Epirubicin—sarcoma	0.000262	0.00123	CcSEcCtD
Alosetron—Infection—Epirubicin—sarcoma	0.000258	0.00121	CcSEcCtD
Alosetron—Cough—Doxorubicin—sarcoma	0.000257	0.0012	CcSEcCtD
Alosetron—Hypertension—Doxorubicin—sarcoma	0.000254	0.00119	CcSEcCtD
Alosetron—Skin disorder—Epirubicin—sarcoma	0.000252	0.00118	CcSEcCtD
Alosetron—Hyperhidrosis—Epirubicin—sarcoma	0.000251	0.00118	CcSEcCtD
Alosetron—Myalgia—Doxorubicin—sarcoma	0.000251	0.00117	CcSEcCtD
Alosetron—Anxiety—Doxorubicin—sarcoma	0.00025	0.00117	CcSEcCtD
Alosetron—Discomfort—Doxorubicin—sarcoma	0.000248	0.00116	CcSEcCtD
Alosetron—Dry mouth—Doxorubicin—sarcoma	0.000245	0.00115	CcSEcCtD
Alosetron—Confusional state—Doxorubicin—sarcoma	0.000242	0.00114	CcSEcCtD
Alosetron—Infection—Doxorubicin—sarcoma	0.000239	0.00112	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000237	0.00111	CcSEcCtD
Alosetron—Skin disorder—Doxorubicin—sarcoma	0.000233	0.00109	CcSEcCtD
Alosetron—Hyperhidrosis—Doxorubicin—sarcoma	0.000232	0.00109	CcSEcCtD
Alosetron—Fatigue—Epirubicin—sarcoma	0.000224	0.00105	CcSEcCtD
Alosetron—Pain—Epirubicin—sarcoma	0.000222	0.00104	CcSEcCtD
Alosetron—Constipation—Epirubicin—sarcoma	0.000222	0.00104	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000219	0.00103	CcSEcCtD
Alosetron—Feeling abnormal—Epirubicin—sarcoma	0.000214	0.001	CcSEcCtD
Alosetron—Fatigue—Doxorubicin—sarcoma	0.000207	0.000971	CcSEcCtD
Alosetron—Urticaria—Epirubicin—sarcoma	0.000206	0.000967	CcSEcCtD
Alosetron—Pain—Doxorubicin—sarcoma	0.000206	0.000963	CcSEcCtD
Alosetron—Constipation—Doxorubicin—sarcoma	0.000206	0.000963	CcSEcCtD
Alosetron—Feeling abnormal—Doxorubicin—sarcoma	0.000198	0.000928	CcSEcCtD
Alosetron—Hypersensitivity—Epirubicin—sarcoma	0.000191	0.000897	CcSEcCtD
Alosetron—Urticaria—Doxorubicin—sarcoma	0.000191	0.000895	CcSEcCtD
Alosetron—Asthenia—Epirubicin—sarcoma	0.000186	0.000873	CcSEcCtD
Alosetron—Hypersensitivity—Doxorubicin—sarcoma	0.000177	0.00083	CcSEcCtD
Alosetron—Asthenia—Doxorubicin—sarcoma	0.000172	0.000808	CcSEcCtD
Alosetron—Vomiting—Epirubicin—sarcoma	0.000165	0.000774	CcSEcCtD
Alosetron—Rash—Epirubicin—sarcoma	0.000164	0.000767	CcSEcCtD
Alosetron—Dermatitis—Epirubicin—sarcoma	0.000164	0.000767	CcSEcCtD
Alosetron—Headache—Epirubicin—sarcoma	0.000163	0.000763	CcSEcCtD
Alosetron—Nausea—Epirubicin—sarcoma	0.000154	0.000723	CcSEcCtD
Alosetron—Vomiting—Doxorubicin—sarcoma	0.000153	0.000716	CcSEcCtD
Alosetron—Rash—Doxorubicin—sarcoma	0.000152	0.00071	CcSEcCtD
Alosetron—Dermatitis—Doxorubicin—sarcoma	0.000151	0.000709	CcSEcCtD
Alosetron—Headache—Doxorubicin—sarcoma	0.000151	0.000706	CcSEcCtD
Alosetron—Nausea—Doxorubicin—sarcoma	0.000143	0.000669	CcSEcCtD
